# Bio-probiotic confectionery Gummies, chewable tablets and chocolate carrying a defined colony-forming-unit dose of live probiotic strains — the supplement format that removes pill fatigue and swallowing barriers while remaining shelf-stable, now the fastest-growing segment of the digestive-health aisle. Source: https://en.bioecon.ru/technology/bio-probiotic-confectionery/ Updated: 2026-08-18 ## Overview and value chain Markers: [EC: FDA DSHEA structure/function claims & EFSA health-claim authorisation | OECD: Food systems | Regulator: FDA (USA), EFSA (EU), NMPA (China)] Bio-probiotic confectionery is the class of gummies, chewable tablets and chocolate that carry a defined, label-claimed colony-forming-unit (CFU) dose of one or more live probiotic strains — typically Lactobacillus rhamnosus GG, Lactobacillus acidophilus, Bifidobacterium animalis spp. lactis BB-12 — in a low-water-activity sugar, sugar-alcohol or sugar-free matrix. The format removes the swallowing barrier and pill fatigue of capsules and tablets, the two largest compliance obstacles for digestive-health supplements, and the low-water-activity confection matrix (aw ~0.5–0.7) keeps the live strains above their labelled CFU count through a 12–24-month ambient shelf life without refrigeration. The platform is mid-transformation along four axes: the move from generic "digestive health" to strain-specific, clinically-substantiated formulations (Olly Precise Probiotics, three targeted blends); the shift from sugared gummies to sugar-alcohol and sugar-free formats (xylitol, erythritol, allulose) under metabolic-health pressure; the industrialisation of B2B strain-supply and stability testing (Chr. Hansen, now Novonesis); and the convergence of dietary-supplement and functional-food regulation (FDA DSHEA structure/function claims, EFSA health-claim authorisation, NMPA health-food registration). The key directions of bio-probiotic confectionery are: 1. **Targeted multi-strain gummies (Olly Precise Probiotics, Culturelle Kids):** science-backed lines moving beyond generic "digestive health" to strain-specific, clinically-substantiated formulations positioned on immunity, regularity and gut-barrier health. 2. **Sugar-alcohol and sugar-free matrices:** xylitol, erythritol and allulose replacing sucrose and glucose syrup under metabolic-health pressure while holding the low water activity that keeps strains viable. 3. **B2B strain supply and stability testing (Chr. Hansen / Novonesis):** industrial supply of documented probiotic strains (LGG, BB-12, LA-5) with matched stability data for the confectionery matrix and claim. 4. **Converged supplement and functional-food regulation:** FDA DSHEA structure/function claims, EFSA health-claim authorisation and NMPA health-food (蓝色帽子) registration framing the claim, dose and shelf-life evidence bar. ### Sectoral value chain ``` [strain selection & documentation] ──> [B2B culture production] ──> [confection matrix cook] │ (low-water-activity + stability testing) │ ▼ [shelf-stable bottle/jar] <─── [gummy depositing + cooling] <─────┘ ``` ### Value chain levels | Level | Description | Key inputs/outputs | |:---|:---|:---| | **Strain selection** | choosing documented strains (LGG, BB-12, LA-5) with matching clinical dossier | **In:** strain library, dossier. **Out:** selected strain(s). | | **B2B culture production** | fermentation, concentration and freeze-drying of the strain to a concentrated CFU powder | **In:** selected strain, media. **Out:** freeze-dried culture. | | **Confection matrix cook** | cooking sugar/sugar-alcohol/glucose syrup to target solids and water activity | **In:** syrup, gelling agent. **Out:** cooked matrix. | | **Culture addition & depositing** | dosing the culture into the cooled matrix and depositing into moulds | **In:** cooked matrix, culture. **Out:** deposited gummies. | | **Stability & CFU verification** | accelerated and real-time stability testing confirming CFU above label through shelf life | **In:** deposited gummies. **Out:** shelf-stable product. | | **Packaging & claim substantiation** | bottle/jar packaging with DSHEA/EFSA/NMPA-compliant label claim | **In:** shelf-stable product. **Out:** released retail SKU. | Cross-cutting technologies of the sector: - **Probiotic confectionery (Probiotic Confectionery):** gummy, chewable and chocolate delivery of a defined CFU dose, the compliance-friendly format. - **Probiotic strain stability (Probiotic Strain Stability):** low-water-activity matrix engineering keeping live strains above labelled CFU through shelf life. --- ## US The United States is the centre of the probiotic-gummy consumer category: Olly (San Francisco, founded 2014, a Unilever company) and SmartyPants (Los Angeles, founded 2010) lead the supplement-aisle gummy segment, while Culturelle (founded 1999, the Lactobacillus rhamnosus GG brand now under DSM-Firmenich's i-Health division) anchors the strain- specific, clinically-substantiated end. FDA's DSHEA structure/function claim framework defines the claim and evidence bar. ### targeted multi-strain gummies, DSHEA claim framework, brand consolidation - **Olly — Precise Probiotics:** science-backed line of three targeted probiotic formulations extending Olly's gut-health portfolio, a Unilever company since 2019. - **SmartyPants — probiotic gummies:** supplement-aisle gummy brand carrying multi-strain probiotic doses. - **Culturelle — Kids Fiber + Probiotic Gummies:** strain-specific Lactobacillus rhamnosus GG products under DSM-Firmenich i-Health. - **FDA DSHEA:** structure/function claim framework defining gut-health and immune claims for dietary-supplement confectionery. --- ## CN China is the largest and fastest-growing probiotic-confectionery market in Asia: domestic supplement leaders led by By-Health (汤臣倍健, SZSE:300146, founded 1995) have built a probiotic-gummy segment (益生菌软糖) on self-owned strain libraries with multi-stage clinical evidence, and the country's health-food registration (蓝色帽子) regime sets a higher pre-market evidence bar than US DSHEA. Domestic strain-supply and confection manufacturing capacity is rapidly localising, though premium documented strains are still partly imported from Europe. ### By-Health lead, 蓝帽子 health-food registration, localising strain supply - **By-Health (汤臣倍健):** SZSE:300146 supplement leader with self-owned probiotic strains backed by in-vitro, animal and human clinical studies, extending into probiotic gummies for gut-microbiome and immune positioning. - **NMPA 蓝色帽子 (Blue Hat) health-food registration:** Chinese pre-market approval requiring functional and safety evidence — a higher bar than US DSHEA for gut-health claims. - **Localising strain supply:** domestic fermentation and freeze-dried culture capacity scaling fast, with premium documented strains (LGG, BB-12) still partly imported from Europe. --- ## EU Europe is the centre of the B2B strain-supply layer that underwrites the whole category: Chr. Hansen (Hørsholm, Denmark, founded 1874) — now Novonesis following the January 2024 merger with Novozymes — supplies the documented strains (Lactobacillus GG, BB-12, LA-5) with matched stability and clinical dossiers that gummy and supplement brands build their CFU claims on. EFSA's health-claim authorisation regime sets the European evidence bar, markedly stricter than US DSHEA. ### Chr. Hansen / Novonesis strain supply, EFSA health-claim regime - **Chr. Hansen (now Novonesis):** B2B supply of documented probiotic strains (LGG, BB-12, LA-5) with matched stability data for the confectionery matrix; the Chr. Hansen Health & Nutrition division now operates under Novonesis following the 2024 Novozymes merger. - **EFSA health-claim authorisation:** the European regime requiring pre-market scientific substantiation of any probiotic health claim — markedly stricter than US DSHEA. --- ## Leading companies and research institutes | Company / Institute | Country | Key products / platforms | Tech features | Status 2026 | |:---|:---|:---|:---|:---| | **Olly** | 🇺🇸 USA | *Precise Probiotics gummies* | Science-backed multi-strain targeted blends; Unilever company (founded 2014) | Commercial | | **SmartyPants** | 🇺🇸 USA | *Probiotic gummy vitamins* | Supplement-aisle gummy brand carrying multi-strain probiotic doses (founded 2010) | Commercial | | **Culturelle** | 🇺🇸 USA | *Kids Fiber + Probiotic Gummies* | Strain-specific Lactobacillus rhamnosus GG (DSM-Firmenich i-Health, since 1999) | Commercial | | **Chr. Hansen** | 🇩🇰 Denmark | *LGG, BB-12, LA-5 strain portfolio* | B2B documented strains + stability data; now Novonesis after 2024 merger (founded 1874) | Commercial | | **By-Health** | 🇨🇳 China | *益生菌软糖 (probiotic gummies)* | Self-owned strain library with clinical evidence (SZSE:300146, founded 1995) | Commercial | --- ## Tech stack and innovations The stack combines documented strain supply, low-water-activity matrix engineering and stability-verified CFU dosing into a shelf-stable, compliance-friendly supplement format. 1. **Documented strain supply (Documented Strain Supply):** - Chr. Hansen (Novonesis) and equivalent B2B strain houses supplying documented strains (LGG, BB-12, LA-5) with matching clinical dossiers; - self-owned strain libraries with in-house clinical evidence (By-Health) for differentiation. 2. **Low-water-activity matrix engineering (Low-Water-Activity Matrix):** - sugar, glucose syrup and sugar-alcohol (xylitol, erythritol, allulose) matrices cooked to aw ~0.5–0.7; - low water activity keeps live strains above labelled CFU through a 12–24-month ambient shelf life without refrigeration. 3. **Culture addition & depositing (Culture Addition & Depositing):** - freeze-dried culture dosed into the cooled matrix below strain-lethal temperature, then deposited into starch or rubber moulds; - gummy, chewable, fondant and chocolate formats covering the supplement-aisle range. 4. **Stability & CFU verification (Stability & CFU Verification):** - accelerated and real-time stability testing confirming overage CFU holds above the label claim through shelf life; - DSHEA/EFSA/NMPA-compliant claim and dose substantiation. --- ## Value chains and production pipelines ### Industrial pipeline of a probiotic-gummy line (DSHEA / EFSA / NMPA) ``` ┌───────────────────────────┐ ┌───────────────────────────┐ │ 1. Strain selection │ ───> │ 2. B2B culture production │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 4. Culture dosing + deposit│ <─── │ 3. Matrix cook │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 5. Stability & CFU check │ ───> │ 6. Packaging & claim │ └───────────────────────────┘ └───────────────────────────┘ ``` #### Stage 1: Strain selection A documented strain (Lactobacillus GG, BB-12, LA-5) with a matching clinical dossier is selected against the target health claim — gut regularity, immune support or gut-barrier function. #### Stage 2: B2B culture production The strain is fermented, concentrated and freeze-dried by a B2B strain house (Chr. Hansen/Novonesis) to a concentrated CFU powder, with overage sized for shelf-life die-off. #### Stage 3: Matrix cook Sugar, glucose syrup and a sugar-alcohol (xylitol, erythritol, allulose) are cooked with a gelling agent (gelatin, pectin, agar) to target solids and a water activity of ~0.5–0.7. #### Stage 4: Culture dosing and depositing The freeze-dried culture is dosed into the cooled matrix below the strain-lethal temperature, then deposited into starch or rubber moulds and cooled to set. #### Stage 5: Stability and CFU check Accelerated and real-time stability testing confirms the overage CFU holds above the labelled dose through the 12–24-month ambient shelf life, with water-activity and temperature mapping. #### Stage 6: Packaging and claim The set gummies are bottled or jarred with a DSHEA/EFSA/NMPA-compliant structure/function or health claim on the label, completing the released retail SKU.